Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells
AIM:To investigate the effects of schisandrin B (Sch B) on free fatty acid (FFA)-induced steatosis in L-02 cells.METHODS:Cellular steatosis was induced by incubating L-02 cells with a FFA mixture (oleate and palmitate at the ratio of 2:1) for 24 h.Cytotoxicity and apoptosis were evaluated by 3-(4,5-...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2011-05, Vol.17 (19), p.2379-2388 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2388 |
---|---|
container_issue | 19 |
container_start_page | 2379 |
container_title | World journal of gastroenterology : WJG |
container_volume | 17 |
creator | Chu, Jian-Hong Wang, Hui Ye, Yan Chan, Ping-Kei Pan, Si-Yuan Fong, Wang-Fun Yu, Zhi-Ling |
description | AIM:To investigate the effects of schisandrin B (Sch B) on free fatty acid (FFA)-induced steatosis in L-02 cells.METHODS:Cellular steatosis was induced by incubating L-02 cells with a FFA mixture (oleate and palmitate at the ratio of 2:1) for 24 h.Cytotoxicity and apoptosis were evaluated by 3-(4,5-dmethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and Annexin V/propidium iodide staining,respectively.Cellular total lipid was determined using a photocolorimetric method after Nile red staining,and triglyceride content was measured using an enzymatic kit.To study the effects of Sch B on steatosis,L-02 cells were treated with Sch B (1-100 μmol/L) in the absence or presence of 1 mmol/L FFA for 24 h,and cellular total lipid and triglyceride levels were measured.To explore the mechanisms of action of Sch B in the steatotic L-02 cells,mRNA levels of several regulators of hepatic lipid metabolism including adipose differentiation related protein (ADRP),sterol regulatory element binding protein 1 (SREBP-1),peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ were measured by quantitative real-time polymerase chain reaction (PCR),and protein levels of ADRP and SREBP-1 were measured by immunoblotting.RESULTS:Treatment with 1 mmol/L FFA for 24 h induced intracellular lipid accumulation in L-02 cells comparable to that in human steatotic livers without causing apparent apoptosis and cytotoxicity.Sch B mitigated cellular total lipid and triglyceride accumulations in the steatotic L-02 cells in a dose-dependent manner.Quantitative real-time PCR and Western blot analyses revealed that treatment of L-02 cells with 100 μmol/L Sch B reverted the FFA-stimulated up-regulation of ADRP and SREBP-1.CONCLUSION:Sch B inhibits FFA-induced steatosis in L-02 cells by,at least in part,reversing the up-regulation of ADRP and SREBP-1. |
doi_str_mv | 10.3748/wjg.v17.i19.2379 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3103790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>38236644</cqvip_id><sourcerecordid>21633637</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-a7df0cb49dad587dc933d3f5689d022bc3dae20c97804158d4d12b5ee338b173</originalsourceid><addsrcrecordid>eNpVkMtOwzAQRS0EoqWwZ4XMByTYniRONkhQ8ahUiU1ZW44fiavUKXFa1L8nVUsFq1nce89IB6FbSmLgSf7wvaziLeWxo0XMgBdnaMwYLSKWJ-QcjSkhPCqA8RG6CmFJCANI2SUaMZoBZMDH6HPma1e6vu122FhrVI9bi4OqXZBed87jZ9x6bDtjsJV9v8NSOR05rzfKaBx6I_s2uICH5jwiDCvTNOEaXVjZBHNzvBO0eH1ZTN-j-cfbbPo0j1TCaB9Jri1RZVJoqdOca1UAaLBplheaMFYq0NIwogqek4SmuU40ZWVqDEBeUg4T9HjArjflymhlfN_JRqw7t5LdTrTSif-Jd7Wo2q0ASgZbZACQA0B1bQidsactJWJvWAyGxWBYDIbF3vAwufv78zT4VToU7o_MuvXVl_PVqQM5gyxLEvgBZ1KFBA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Chu, Jian-Hong ; Wang, Hui ; Ye, Yan ; Chan, Ping-Kei ; Pan, Si-Yuan ; Fong, Wang-Fun ; Yu, Zhi-Ling</creator><creatorcontrib>Chu, Jian-Hong ; Wang, Hui ; Ye, Yan ; Chan, Ping-Kei ; Pan, Si-Yuan ; Fong, Wang-Fun ; Yu, Zhi-Ling</creatorcontrib><description>AIM:To investigate the effects of schisandrin B (Sch B) on free fatty acid (FFA)-induced steatosis in L-02 cells.METHODS:Cellular steatosis was induced by incubating L-02 cells with a FFA mixture (oleate and palmitate at the ratio of 2:1) for 24 h.Cytotoxicity and apoptosis were evaluated by 3-(4,5-dmethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and Annexin V/propidium iodide staining,respectively.Cellular total lipid was determined using a photocolorimetric method after Nile red staining,and triglyceride content was measured using an enzymatic kit.To study the effects of Sch B on steatosis,L-02 cells were treated with Sch B (1-100 μmol/L) in the absence or presence of 1 mmol/L FFA for 24 h,and cellular total lipid and triglyceride levels were measured.To explore the mechanisms of action of Sch B in the steatotic L-02 cells,mRNA levels of several regulators of hepatic lipid metabolism including adipose differentiation related protein (ADRP),sterol regulatory element binding protein 1 (SREBP-1),peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ were measured by quantitative real-time polymerase chain reaction (PCR),and protein levels of ADRP and SREBP-1 were measured by immunoblotting.RESULTS:Treatment with 1 mmol/L FFA for 24 h induced intracellular lipid accumulation in L-02 cells comparable to that in human steatotic livers without causing apparent apoptosis and cytotoxicity.Sch B mitigated cellular total lipid and triglyceride accumulations in the steatotic L-02 cells in a dose-dependent manner.Quantitative real-time PCR and Western blot analyses revealed that treatment of L-02 cells with 100 μmol/L Sch B reverted the FFA-stimulated up-regulation of ADRP and SREBP-1.CONCLUSION:Sch B inhibits FFA-induced steatosis in L-02 cells by,at least in part,reversing the up-regulation of ADRP and SREBP-1.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v17.i19.2379</identifier><identifier>PMID: 21633637</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Co., Limited</publisher><subject>Antineoplastic Agents - pharmacology ; Antineoplastic Agents - therapeutic use ; Apoptosis - drug effects ; Cell Line ; Cyclooctanes - pharmacology ; Cyclooctanes - therapeutic use ; Dose-Response Relationship, Drug ; Fatty Acids, Nonesterified - adverse effects ; Fatty Acids, Nonesterified - pharmacology ; Fatty Liver - chemically induced ; Fatty Liver - drug therapy ; Fatty Liver - pathology ; Hepatocytes - drug effects ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Humans ; Lignans - pharmacology ; Lignans - therapeutic use ; Lipid Metabolism - drug effects ; Liver - drug effects ; Liver - metabolism ; Liver - pathology ; Membrane Proteins - metabolism ; Original ; Perilipin-2 ; Polycyclic Compounds - pharmacology ; Polycyclic Compounds - therapeutic use ; Sterol Regulatory Element Binding Protein 1 - metabolism ; Treatment Outcome ; Up-Regulation - drug effects ; 五味子乙素 ; 变性 ; 固醇调节元件结合蛋白 ; 实时定量PCR ; 抑制作用 ; 游离脂肪酸 ; 细胞凋亡 ; 诱导</subject><ispartof>World journal of gastroenterology : WJG, 2011-05, Vol.17 (19), p.2379-2388</ispartof><rights>2011 Baishideng Publishing Group Co., Limited. All rights reserved. 2011</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-a7df0cb49dad587dc933d3f5689d022bc3dae20c97804158d4d12b5ee338b173</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103790/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103790/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21633637$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chu, Jian-Hong</creatorcontrib><creatorcontrib>Wang, Hui</creatorcontrib><creatorcontrib>Ye, Yan</creatorcontrib><creatorcontrib>Chan, Ping-Kei</creatorcontrib><creatorcontrib>Pan, Si-Yuan</creatorcontrib><creatorcontrib>Fong, Wang-Fun</creatorcontrib><creatorcontrib>Yu, Zhi-Ling</creatorcontrib><title>Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM:To investigate the effects of schisandrin B (Sch B) on free fatty acid (FFA)-induced steatosis in L-02 cells.METHODS:Cellular steatosis was induced by incubating L-02 cells with a FFA mixture (oleate and palmitate at the ratio of 2:1) for 24 h.Cytotoxicity and apoptosis were evaluated by 3-(4,5-dmethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and Annexin V/propidium iodide staining,respectively.Cellular total lipid was determined using a photocolorimetric method after Nile red staining,and triglyceride content was measured using an enzymatic kit.To study the effects of Sch B on steatosis,L-02 cells were treated with Sch B (1-100 μmol/L) in the absence or presence of 1 mmol/L FFA for 24 h,and cellular total lipid and triglyceride levels were measured.To explore the mechanisms of action of Sch B in the steatotic L-02 cells,mRNA levels of several regulators of hepatic lipid metabolism including adipose differentiation related protein (ADRP),sterol regulatory element binding protein 1 (SREBP-1),peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ were measured by quantitative real-time polymerase chain reaction (PCR),and protein levels of ADRP and SREBP-1 were measured by immunoblotting.RESULTS:Treatment with 1 mmol/L FFA for 24 h induced intracellular lipid accumulation in L-02 cells comparable to that in human steatotic livers without causing apparent apoptosis and cytotoxicity.Sch B mitigated cellular total lipid and triglyceride accumulations in the steatotic L-02 cells in a dose-dependent manner.Quantitative real-time PCR and Western blot analyses revealed that treatment of L-02 cells with 100 μmol/L Sch B reverted the FFA-stimulated up-regulation of ADRP and SREBP-1.CONCLUSION:Sch B inhibits FFA-induced steatosis in L-02 cells by,at least in part,reversing the up-regulation of ADRP and SREBP-1.</description><subject>Antineoplastic Agents - pharmacology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Apoptosis - drug effects</subject><subject>Cell Line</subject><subject>Cyclooctanes - pharmacology</subject><subject>Cyclooctanes - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fatty Acids, Nonesterified - adverse effects</subject><subject>Fatty Acids, Nonesterified - pharmacology</subject><subject>Fatty Liver - chemically induced</subject><subject>Fatty Liver - drug therapy</subject><subject>Fatty Liver - pathology</subject><subject>Hepatocytes - drug effects</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Humans</subject><subject>Lignans - pharmacology</subject><subject>Lignans - therapeutic use</subject><subject>Lipid Metabolism - drug effects</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Membrane Proteins - metabolism</subject><subject>Original</subject><subject>Perilipin-2</subject><subject>Polycyclic Compounds - pharmacology</subject><subject>Polycyclic Compounds - therapeutic use</subject><subject>Sterol Regulatory Element Binding Protein 1 - metabolism</subject><subject>Treatment Outcome</subject><subject>Up-Regulation - drug effects</subject><subject>五味子乙素</subject><subject>变性</subject><subject>固醇调节元件结合蛋白</subject><subject>实时定量PCR</subject><subject>抑制作用</subject><subject>游离脂肪酸</subject><subject>细胞凋亡</subject><subject>诱导</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMtOwzAQRS0EoqWwZ4XMByTYniRONkhQ8ahUiU1ZW44fiavUKXFa1L8nVUsFq1nce89IB6FbSmLgSf7wvaziLeWxo0XMgBdnaMwYLSKWJ-QcjSkhPCqA8RG6CmFJCANI2SUaMZoBZMDH6HPma1e6vu122FhrVI9bi4OqXZBed87jZ9x6bDtjsJV9v8NSOR05rzfKaBx6I_s2uICH5jwiDCvTNOEaXVjZBHNzvBO0eH1ZTN-j-cfbbPo0j1TCaB9Jri1RZVJoqdOca1UAaLBplheaMFYq0NIwogqek4SmuU40ZWVqDEBeUg4T9HjArjflymhlfN_JRqw7t5LdTrTSif-Jd7Wo2q0ASgZbZACQA0B1bQidsactJWJvWAyGxWBYDIbF3vAwufv78zT4VToU7o_MuvXVl_PVqQM5gyxLEvgBZ1KFBA</recordid><startdate>20110521</startdate><enddate>20110521</enddate><creator>Chu, Jian-Hong</creator><creator>Wang, Hui</creator><creator>Ye, Yan</creator><creator>Chan, Ping-Kei</creator><creator>Pan, Si-Yuan</creator><creator>Fong, Wang-Fun</creator><creator>Yu, Zhi-Ling</creator><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20110521</creationdate><title>Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells</title><author>Chu, Jian-Hong ; Wang, Hui ; Ye, Yan ; Chan, Ping-Kei ; Pan, Si-Yuan ; Fong, Wang-Fun ; Yu, Zhi-Ling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-a7df0cb49dad587dc933d3f5689d022bc3dae20c97804158d4d12b5ee338b173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Apoptosis - drug effects</topic><topic>Cell Line</topic><topic>Cyclooctanes - pharmacology</topic><topic>Cyclooctanes - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fatty Acids, Nonesterified - adverse effects</topic><topic>Fatty Acids, Nonesterified - pharmacology</topic><topic>Fatty Liver - chemically induced</topic><topic>Fatty Liver - drug therapy</topic><topic>Fatty Liver - pathology</topic><topic>Hepatocytes - drug effects</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Humans</topic><topic>Lignans - pharmacology</topic><topic>Lignans - therapeutic use</topic><topic>Lipid Metabolism - drug effects</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Membrane Proteins - metabolism</topic><topic>Original</topic><topic>Perilipin-2</topic><topic>Polycyclic Compounds - pharmacology</topic><topic>Polycyclic Compounds - therapeutic use</topic><topic>Sterol Regulatory Element Binding Protein 1 - metabolism</topic><topic>Treatment Outcome</topic><topic>Up-Regulation - drug effects</topic><topic>五味子乙素</topic><topic>变性</topic><topic>固醇调节元件结合蛋白</topic><topic>实时定量PCR</topic><topic>抑制作用</topic><topic>游离脂肪酸</topic><topic>细胞凋亡</topic><topic>诱导</topic><toplevel>online_resources</toplevel><creatorcontrib>Chu, Jian-Hong</creatorcontrib><creatorcontrib>Wang, Hui</creatorcontrib><creatorcontrib>Ye, Yan</creatorcontrib><creatorcontrib>Chan, Ping-Kei</creatorcontrib><creatorcontrib>Pan, Si-Yuan</creatorcontrib><creatorcontrib>Fong, Wang-Fun</creatorcontrib><creatorcontrib>Yu, Zhi-Ling</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chu, Jian-Hong</au><au>Wang, Hui</au><au>Ye, Yan</au><au>Chan, Ping-Kei</au><au>Pan, Si-Yuan</au><au>Fong, Wang-Fun</au><au>Yu, Zhi-Ling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2011-05-21</date><risdate>2011</risdate><volume>17</volume><issue>19</issue><spage>2379</spage><epage>2388</epage><pages>2379-2388</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM:To investigate the effects of schisandrin B (Sch B) on free fatty acid (FFA)-induced steatosis in L-02 cells.METHODS:Cellular steatosis was induced by incubating L-02 cells with a FFA mixture (oleate and palmitate at the ratio of 2:1) for 24 h.Cytotoxicity and apoptosis were evaluated by 3-(4,5-dmethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and Annexin V/propidium iodide staining,respectively.Cellular total lipid was determined using a photocolorimetric method after Nile red staining,and triglyceride content was measured using an enzymatic kit.To study the effects of Sch B on steatosis,L-02 cells were treated with Sch B (1-100 μmol/L) in the absence or presence of 1 mmol/L FFA for 24 h,and cellular total lipid and triglyceride levels were measured.To explore the mechanisms of action of Sch B in the steatotic L-02 cells,mRNA levels of several regulators of hepatic lipid metabolism including adipose differentiation related protein (ADRP),sterol regulatory element binding protein 1 (SREBP-1),peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ were measured by quantitative real-time polymerase chain reaction (PCR),and protein levels of ADRP and SREBP-1 were measured by immunoblotting.RESULTS:Treatment with 1 mmol/L FFA for 24 h induced intracellular lipid accumulation in L-02 cells comparable to that in human steatotic livers without causing apparent apoptosis and cytotoxicity.Sch B mitigated cellular total lipid and triglyceride accumulations in the steatotic L-02 cells in a dose-dependent manner.Quantitative real-time PCR and Western blot analyses revealed that treatment of L-02 cells with 100 μmol/L Sch B reverted the FFA-stimulated up-regulation of ADRP and SREBP-1.CONCLUSION:Sch B inhibits FFA-induced steatosis in L-02 cells by,at least in part,reversing the up-regulation of ADRP and SREBP-1.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Co., Limited</pub><pmid>21633637</pmid><doi>10.3748/wjg.v17.i19.2379</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2011-05, Vol.17 (19), p.2379-2388 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3103790 |
source | MEDLINE; Baishideng "World Journal of" online journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Apoptosis - drug effects Cell Line Cyclooctanes - pharmacology Cyclooctanes - therapeutic use Dose-Response Relationship, Drug Fatty Acids, Nonesterified - adverse effects Fatty Acids, Nonesterified - pharmacology Fatty Liver - chemically induced Fatty Liver - drug therapy Fatty Liver - pathology Hepatocytes - drug effects Hepatocytes - metabolism Hepatocytes - pathology Humans Lignans - pharmacology Lignans - therapeutic use Lipid Metabolism - drug effects Liver - drug effects Liver - metabolism Liver - pathology Membrane Proteins - metabolism Original Perilipin-2 Polycyclic Compounds - pharmacology Polycyclic Compounds - therapeutic use Sterol Regulatory Element Binding Protein 1 - metabolism Treatment Outcome Up-Regulation - drug effects 五味子乙素 变性 固醇调节元件结合蛋白 实时定量PCR 抑制作用 游离脂肪酸 细胞凋亡 诱导 |
title | Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T08%3A26%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20effect%20of%20schisandrin%20B%20on%20free%20fatty%20acid-induced%20steatosis%20in%20L-02%20cells&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Chu,%20Jian-Hong&rft.date=2011-05-21&rft.volume=17&rft.issue=19&rft.spage=2379&rft.epage=2388&rft.pages=2379-2388&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v17.i19.2379&rft_dat=%3Cpubmed_cross%3E21633637%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21633637&rft_cqvip_id=38236644&rfr_iscdi=true |